Articles related to RARE CONDITIONS & DISEASES

Similar efficacy was observed in pediatric patients aged 12 years and older – demonstrating consistent treatment benefit across age groups in the pivotal trial.

Rates increased 3.7% annually with goblet cell tumors nearly five times more common in 1980 births versus 1945 births, suggesting generational risk factors.

SEER registry analysis revealed striking birth cohort effects with appendiceal adenocarcinoma rates more than quadrupling in the 1985 birth cohort compared to the 1945 reference group.

Prior to CDC’s Sickle Cell Data Collection program, the actual number of Americans living with sickle cell disease was unknown, with current estimates of 100,000 patients based on systematic data collection efforts now at risk.

“In the Eastern High Sierras, hantavirus cases typically occur later in the spring and in the summer… The occurrence of three cases in a short period has me worried, especially this early in the year.”

In terms of overall survival rates, the tricaprin group had 100% three-year and five-year survival rates. In contrast, the control group had a 78.6% three-year survival rate and a 68.1% five-year survival rate.